These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 20058680

  • 1. [The preventive effect of 23-valent pneumococcal polysaccharide vaccine against drug-resistant Streptococcus pneumonia in patients with chronic respiratory disease].
    Kobayashi N, Watanuki Y, Miyazawa N, Kudo M, Inoue S, Sato T, Mishina K, Takahashi H, Kaneko T, Ishigatsubo Y.
    Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1063-9. PubMed ID: 20058680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M, Reinert RR, van der Linden M.
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of pneumococcal polysaccharide vaccine in older patients with chronic respiratory diseases].
    Watanuki Y, Takahashi H, Ogura T, Miyazawa N, Nakamura M, Hashizume T, Kozawa S, Tagawa A.
    Nihon Kokyuki Gakkai Zasshi; 2006 Apr; 44(4):305-11. PubMed ID: 16681246
    [Abstract] [Full Text] [Related]

  • 7. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [Abstract] [Full Text] [Related]

  • 8. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis.
    Xu Q, Surendran N, Verhoeven D, Klapa J, Ochs M, Pichichero ME.
    Vaccine; 2015 Feb 18; 33(8):993-1000. PubMed ID: 25597944
    [Abstract] [Full Text] [Related]

  • 9. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ.
    Clin Microbiol Infect; 2009 Apr 18; 15 Suppl 3():4-6. PubMed ID: 19366362
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A, Carbonnelle S, Verhaegen J, Schatt P, De Bel A, Jordens P, Jacobs F, Dediste A, Verschuren F, Huang TD, Tulkens PM, Glupczynski Y, Van Bambeke F.
    Int J Antimicrob Agents; 2012 Mar 18; 39(3):208-16. PubMed ID: 22245497
    [Abstract] [Full Text] [Related]

  • 11. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ, Klugman KP, Pichichero M.
    Pediatr Infect Dis J; 2007 Feb 18; 26(2):123-8. PubMed ID: 17259873
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.
    Sá-Leão R, Nunes S, Brito-Avô A, Frazão N, Simões AS, Crisóstomo MI, Paulo AC, Saldanha J, Santos-Sanches I, de Lencastre H.
    Clin Microbiol Infect; 2009 Nov 18; 15(11):1002-7. PubMed ID: 19392883
    [Abstract] [Full Text] [Related]

  • 14. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.
    Pediatr Infect Dis J; 2009 Nov 18; 28(11):990-5. PubMed ID: 19536041
    [Abstract] [Full Text] [Related]

  • 15. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.
    Ortqvist A, Hedlund J, Kalin M.
    Semin Respir Crit Care Med; 2005 Dec 18; 26(6):563-74. PubMed ID: 16388428
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G, Lebanese Inter-Hospital Pneumococcal Surveillance Program.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [Abstract] [Full Text] [Related]

  • 19. Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.
    Imöhl M, Reinert RR, van der Linden M.
    Clin Microbiol Infect; 2009 Nov 31; 15(11):1008-12. PubMed ID: 19681946
    [Abstract] [Full Text] [Related]

  • 20. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY, Hwang KP, Hsieh YC, Cheng CH, Huang FL, Shen YH, Huang YC, Chiu CH, Chen PY, Lin TY.
    Vaccine; 2011 Jul 18; 29(32):5171-7. PubMed ID: 21621578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.